Seeing Is Believing
Currently out of the existing stock ratings of Chris Cooper, 9 are a HOLD (56.25%), 5 are a BUY (31.25%), 2 are a SELL (12.5%).
Analyst Chris Cooper, currently employed at GOLDMAN SACHS, carries an average stock price target met ratio of 50% that have a potential upside of 55.43% achieved within 134 days. Previously, Chris Cooper worked at JEFFERIES.
Chris Cooper’s has documented 26 price targets and ratings displayed on 4 stocks. The coverage is on Healthcare, Consumer Defensive, Financial Services sectors.
Most recent stock forecast was given on RMD, ResMed at 25-Sep-2023.
Analyst best performing recommendations are on RM (REGIONAL MANAGEMENT CORP).
The best stock recommendation documented was for RM (REGIONAL MANAGEMENT CORP) at 3/27/2020. The price target of $31 was fulfilled within 350 days with a profit of $19.01 (158.55%) receiving and performance score of 4.53.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 13-Oct-2025
$225
$21.13 (10.36%)
$227
6 days ago
(08-Jul-2026)
1/4 (25%)
$19.16 (9.31%)
7
Buy Since 31-Oct-2025
$276
$72.13 (35.38%)
$321
6 days ago
(08-Jul-2026)
23/28 (82.14%)
$70.16 (34.08%)
303
Buy Since 12-Jan-2024
$230
$29.71 (14.83%)
$304
27 days ago
(17-Jun-2026)
5/7 (71.43%)
$43.71 (23.46%)
72
Buy Since 10-Dec-2021
$230
$29.71 (14.83%)
$304
27 days ago
(17-Jun-2026)
0/3 (0%)
$43.71 (23.46%)
Buy Since 31-Jan-2025
$270
$69.71 (34.80%)
$340
29 days ago
(15-Jun-2026)
7/10 (70%)
$77.26 (40.09%)
59
What Year was the first public recommendation made by Chris Cooper?